首页> 外文期刊>Drug Safety - Case Reports >Life-Threatening Reaction with Topical 5-Fluorouracil
【24h】

Life-Threatening Reaction with Topical 5-Fluorouracil

机译:局部使用5-氟尿嘧啶威胁生命的反应

获取原文
       

摘要

A 67-year-old man developed a suspected adverse drug reaction during treatment with topical 5-fluorouracil (5-FU) for multiple actinic keratosis of the face, neck, and forearms. The man received topical 5-FU at a dosage of 0.5% for the actinic keratoses. After 1?week, he developed extreme lethargy, fatigue, fever, and mouth erosions. Several days later, and after discontinuation of 5-FU, painful mucositis and systemic side effects occurred, meeting criteria for hospitalization because of dehydration and a 6.8 kg weight loss. Hematology/oncology was consulted, and a possible systemic 5-FU reaction, similar to reactions to intravenous chemotherapy seen with a dihydropyrimidine dehydrogenase deficiency was suggested. The patient was not taking any concurrent medications, and he refused dihydropyrimidine dehydrogenase deficiency testing.
机译:一名67岁的男子在用局部5-氟尿嘧啶(5-FU)治疗脸部,颈部和前臂多发性光化性角化病期间出现了怀疑的药物不良反应。该男子因光化性角化病而接受0.5%剂量的局部5-FU。 1周后,他变得极度嗜睡,疲倦,发烧和口腔糜烂。几天后,在停用5-FU后,发生了痛苦的粘膜炎和全身性副作用,由于脱水和6.8公斤体重减轻,符合住院标准。咨询了血液学/肿瘤学,并提出了可能的全身5-FU反应,类似于对二氢嘧啶脱氢酶缺乏症的静脉化疗的反应。该患者未同时服用任何药物,他拒绝了二氢嘧啶脱氢酶缺乏症检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号